Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 GILD | Gilead Sciences Inc | $166.9b | $129.00 | -0.1% | 15.4M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 NTLA | Intellia Therapeutics, Inc | $2.0b | $13.30 | -9.8% | 7.5M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.8b | $4.22 | -3.6% | 19.7M |
 IMTX | Immatics N.V. Ordinary Shares | $1.6b | $9.80 | -3.7% | 1.1M |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.68 | -9.5% | 4.7M |
 VOR | Vor Biopharma Inc. Common Stock | $0.8b | $13.16 | -8.1% | 597.3K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $1.88 | -8.1% | 8.0M |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.6b | $7.90 | -6.2% | 1.3M |
 IPSC | Century Therapeutics, Inc. Common Stock | $441.9m | $2.14 | -2.7% | 1.9M |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $404.4m | $11.94 | -8.6% | 96.7K |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $385.3m | $6.83 | -11.0% | 361.1K |
 FATE | Fate Therapeutics, Inc. | $331.0m | $1.97 | -10.9% | 3.9M |
 TARA | Protara Therapeutics, Inc. Common Stock | $267.5m | $4.14 | -6.1% | 442.5K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $234.1m | $1.93 | -6.8% | 1.7M |
 NKTX | Nkarta, Inc. Common Stock | $232.5m | $2.50 | -9.8% | 564.0K |
 YDES | YD Bio Limited Ordinary Shares | $228.1m | $3.14 | -0.2% | 19.4K |
 ENGN | enGene Therapeutics Inc. Common Stock | $123.9m | $1.65 | -4.1% | 954.4K |
 ATRA | Atara Biotherapeutics, Inc | $94.7m | $10.01 | -2.5% | 69.0K |
 ANIX | Anixa Biosciences, Inc. | $90.5m | $2.45 | -6.5% | 110.2K |
 ACET | Adicet Bio, Inc. Common Stock | $87.0m | $7.31 | -10.3% | 86.6K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $70.6m | $0.98 | -4.0% | 313.2K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $60.8m | $11.88 | -6.8% | 51.9K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $46.9m | $1.12 | -2.6% | 6.7K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $33.1m | $10.26 | +4.0% | 100.6K |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $29.6m | $0.96 | -4.2% | 225.6K |
 CELU | Celularity Inc. Class A Common Stock | $29.2m | $0.85 | -14.6% | 34.3K |
 INAB | IN8bio, Inc. Common Stock | $18.4m | $1.48 | -3.9% | 73.0K |
 LNAI | Lunai Bioworks Inc. Common Stock | $14.0m | $2.45 | -16.1% | 49.0K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $13.8m | $1.26 | +6.8% | 13.9K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $12.3m | $8.10 | -1.1% | 36.8K |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $9.0m | $0.67 | -8.0% | 196.6K |
 MBIO | Mustang Bio, Inc. | $5.1m | $0.89 | +29.4% | 5.0M |
 CLDI | Calidi Biotherapeutics, Inc. | $3.6m | $0.17 | -4.5% | 1.5M |